1 / 12

Lung Cancer Screening Market Analysis, Size, Share, Growth and Forecast 2030

The global lung cancer screening market size was USD 2.80 Billion in 2021 and is expected to register a revenue CAGR of 8.1% during the forecast period, according to latest analysis by Emergen Research. High cigarette consumption increasing incidence of lung cancer is a major factor driving market revenue growth.

ashwinisharma12
Download Presentation

Lung Cancer Screening Market Analysis, Size, Share, Growth and Forecast 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lung Cancer Screening Market Size Worth USD 5.69 Billion in 2030 Increasing incidence of lung cancer, in turn, rising demand for early diagnosis is a key factor driving lung cancer screening market revenue growth www.emergenresearch.com . 2

  2. Our Model Market Analysis Financial Analysis Distribution Channel Analysis Brand Analysis Custom Market Intelligence Competitor Analysis Product Analysis Custom Research www.emergenresearch.com Demand Analysis Risk Analysis

  3. Business Plan Parameters End Use Analysis Demand Availability Analytics Market Entry Strategy Restructuring & Revival New Product Strategy Product Planning / Strategy SWOT Analysis Marketing / Distribution Channel Feasibility www.emergenresearch.com Customer Identification Survey Competitive Landscape / M&A Feasibility www.emergenresearch.com

  4. Industries We Cater to Food & Beverages Foods & Beverage, Food Ingredients, Food Processing and Equipment, Food Testing and Supply Chain, Health Food and Sports Nutrition, Frozen and Processed Food, Household, Retail Power & Energy Oil and Gas, Electricity, Energy Storage, Environmental, Renewable Energy Automotive Services Information and Tech Electric and Hybrid Vehicles, Off Highway and On Highway Vehicles, Aftermarket and Maintenance, Automotive Parts, Interior and Exterior Materials, Automotive electronics and Systems Data Security, Cloud Computing, IoT and Digitalization, Robotics, Telecom and Networking, Software and Services, Analytics, Semiconductor, Internet and E-Commerce www.emergenresearch.com Pharma & Healthcare Materials and Chemicals Medical Devices, Therapeutics, Biotechnology, Medical Imaging, Healthcare IT, Hospital Management, Diagnostics, Laboratory Equipment, Pharmaceutical Organic Chemicals, Disinfectants and Preservatives, Adhesives and Sealants, Polymers and Resins, Petrochemicals, Agrochemicals and Fertilizers, Paints and Coatings 5

  5. Market Summary The global Lung Cancer Screening Market size was USD 2.80 Billion in 2021 and is expected to register a revenue CAGR of 8.1% during the forecast period, according to latest analysis by Emergen Research. High cigarette consumption increasing incidence of lung cancer is a major factor driving market revenue growth. Lung cancer is one of the main causes of cancer death, accounting for around 25% of all cancer fatalities. Cigarette smoking has been identified as a significant risk factor for developing Non-Small Cell Lung Cancer (NSCLC), along with other environmental and genetic risk factors. Approximately 80% of lung cancer fatalities are caused by smoking, with remaining being caused by secondhand smoke exposure. According to World Health Organization, rise in worldwide tobacco consumption, particularly in Asia, is responsible for a continued rise in lung cancer mortality. In addition, lung cancer cases has been increased due to factors such as water pollution, age, radiation exposure, air pollution (polycyclic aromatic hydrocarbons), and prolonged exposure to certain chemicals, gases, or pollutants including asbestos, beryllium, arsenic, nickel, and chromium. With the advent of genetic and biomarker testing, which has several potential prospects in the market, certain mutations have been found for better-personalized target treatment for patients, thus, there is a rise in demand for lung cancer screening for early diagnosis, which is driving revenue growth of the market.  Read More : https://www.emergenresearch.com/industry-report/lung-cancer-screening-market www.emergenresearch.com

  6. Market Summary Some Key Findings From the Report: The Non-Small Cell Lung Cancer (NSCLC) segment accounted for largest revenue share in 2021. In Asian countries, rapid industrial expansion and suburbanization are factors contributing to rising frequency of NSCLC and increasing need for therapy. Early-stage diagnosis can increase 5-year survival to 80%, which is expected to have significant benefits for outlook of NSCLC, as a result, there is an increasing demand for lung screening technology for early diagnosis, which is driving revenue growth of this segment.  The Low Dose spiral CT (LDCT) scan segment accounted for largest revenue share in 2021. Since the development of LDCT scan, 80%–90% of instances of early-stage, invasive stage I lung cancer can be identified reducing mortality from lung cancer. The diagnostic centers segment accounted for a moderate revenue share in 2021. For elderly people, diagnostic centers are an ideal alternative since they offer individualized treatment and reduce need for repeated hospital visits. In addition to having more control over scheduling of procedures, outpatient surgery facilities can be 45%–60% less expensive than hospitals, which benefits patients, insurance, and taxpayers equally. As a consequence, compared to unexpected hospital events, very few surgeries may need to be postponed or rescheduled.   Request Free Sample @ https://www.emergenresearch.com/request-sample/1328 www.emergenresearch.com

  7. Market Summary • Market Segmentation: • Cancer Type Outlook (Revenue, USD Billion; 2019-2030) • Non-small Cell Lung Cancer (NSCLC) • Small Cell Lung Cancer • Diagnosis Type Outlook (Revenue, USD Billion; 2019-2030) • Low Dose Spiral CT Scan • Chest X-Ray • End-use Outlook (Revenue, USD Billion; 2019-2030) • Hospitals & Clinics • Diagnostic Centers • Request customization @ https://www.emergenresearch.com/request-for-customization/1328

  8. MARKETSEGMENTATION www.emergenresearch.com

  9. Regional Share Dynamics www.emergenresearch.com

  10. LATEST PUBLICATIONS Disposable Syringes Market https://www.emergenresearch.com/industry-report/disposable-syringes-market Medical Footwear Market https://www.emergenresearch.com/industry-report/medical-footwear-market Microneedling Market https://www.emergenresearch.com/industry-report/microneedling-market Mass Spectrometry Market https://www.emergenresearch.com/industry-report/mass-spectrometry-market Custom Antibody Market https://www.emergenresearch.com/industry-report/custom-antibody-market Automated Parking System Market https://www.emergenresearch.com/industry-report/automated-parking-system-market Smart Transportation Market https://www.emergenresearch.com/industry-report/smart-transportation-market www.emergenresearch.com

  11. At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade. Our expertise umbrellas the technological environment of all major industries, and our services help you map your actions to ensure optimal yield. Our analysts utilize their market proficiency to offer actionable insights that help our clients implement profitable strategies and optimize their return on investment. Our services are wide-ranging, right from technological environment analysis to technological profiling that highlights the existing opportunities in the market you can capitalize on to stay ahead of your competitors. About Us www.emergenresearch.com

  12. Lets Talk; Contact Information Reach out to us and our Research Executives will ensure you get the report that meets all your requirements and address all your concerns. 14671 110 Avenue, Surrey, British Columbia, V3R2A9 www.emergenresearch.com www.emergenresearch.com sales@emergenresearch.com +1 (604) 757-9756

More Related